Thus, pretreatment, the most striking association between immune-cell profiles and MS disease activity was an inverse correlation between CD20-expressing CD8+ T cells and the presence, as well as extent, of active CNS inflammation. The gene discussed is CD8A; the disease is myeloid sarcoma.